INJECTION SITE BURNING

This adverse event was reported 780 times

These drugs are most commonly taken by patients reporting INJECTION SITE BURNING:

# Drug Count
0 ADALIMUMAB 562
1 METHOTREXATE SODIUM 230
2 PREDNISONE 185
3 METHOTREXATE 166
4 FOLIC ACID 159
5 TERIPARATIDE 147
6 CELECOXIB 63
7 LEVOTHYROXINE SODIUM 63
8 CALCIUM 56
9 LEVOTHYROXINE SODIUM ANHYDROUS 56
See all common drugs associated with INJECTION SITE BURNING

INJECTION SITE BURNING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FENOPROFEN CALCIUM 1 0.0204
1 MOEXIPRIL HYDROCHLORIDE 1 0.0149
2 TIAGABINE HYDROCHLORIDE 1 0.0119
3 TOLMETIN SODIUM 1 0.0059
4 ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE 1 0.0027
5 ESTERIFIED ESTROGENS, METHYLTESTOSTERONE 1 0.0027
6 PINDOLOL 2 0.0025
7 OXAPROZIN 2 0.0023
8 CALCITONIN SALMON 6 0.0019
9 BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE 1 0.0016
See all drugs enriched for association with INJECTION SITE BURNING

INJECTION SITE BURNING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 6 0.0019
1 Parathyroid Hormone Analog [EPC] 147 0.0013
2 Skin Test Antigen [EPC] 2 0.0011
3 gamma-Aminobutyric Acid A Receptor Agonist [EPC] 1 0.0006
4 Vitamin D [EPC] 175 0.0006
5 Vitamin B12 [EPC] 176 0.0005
6 Photoenhancer [EPC] 2 0.0005
7 Vitamin C [EPC] 185 0.0004
8 Folate Analog [EPC] 22 0.0004
9 Vitamin A [EPC] 22 0.0004
See all drug classes enriched for association with INJECTION SITE BURNING